Hepatitis C Treatment Access
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-07-14 — Cure Hepatitis C Act of 2026: 2026 — Cure Hepatitis C Act of 2026 (introduced): would direct HHS to enter a five-year bulk-purchase contract for hepatitis C antivirals supplying Medicaid, CHIP, incarcerated, uninsured, and IHS patients at no cost; fund testing-and-treatment grants; and waive Medicare Part B/D cost-sharing for those drugs from 2028–2032. (novelty: 3)